
The FDA will allow 20 Philip Morris-owned Zyn nicotine pouch products to carry a modified-risk claim saying switching from cigarettes lowers the risk of several smoking-related diseases. The decision gives Philip Morris a major marketing win for one of the fastest-growing nicotine products as cigarette sales decline in the U.S.










